MedTrace Logo

Asthma Control in Elderly Patients With Montelukast

NCT01147510 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2013-11-13

No results posted yet for this study

Summary

To compare the efficacy of combination therapy of montelukast plus low dose inhaled budesonide and single therapy of medium dose inhaled budesonide on asthma control such as inflammatory markers and clinical indicators and to compare treatment response according to leukotriene related genotypes in elderly patients with asthma

Conditions

  • Persistent Asthma
  • Elderly

Interventions

DRUG

Combination of low ICS and montelukast

Two puffs of Pulmicort ® turbuhaler 200µg/puff between 7 a.m. and 10 a.m and take orally a tablet of Singulair® 10mg one time per day.

DRUG

Monotherapy of medium dose ICS

Two puffs of Pulmicort ® turbuhaler 200µg/puff between 7 a.m. and 10 a.m. and between 7 p.m. and 10 p.m. two times per day

Sponsors & Collaborators

  • Hallym University Medical Center

    collaborator OTHER

  • Wonju Severance Christian Hospital

    collaborator OTHER

  • Korea University Guro Hospital

    collaborator OTHER

  • MCM Vaccines B.V.

    collaborator INDUSTRY

  • Ajou University School of Medicine

    lead OTHER

Principal Investigators

  • Hae-Sim Park, MD, PhD · Ajou University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01147510 on ClinicalTrials.gov